Biology of glial cell line-derived neurotrophic factor (GDNF): implications for the use of GDNF to treat Parkinson's disease.
Lapchak
P A
PA
Amgen Inc., Department of Neuroscience, Thousand Oaks, CA 91320-1789, USA. plapchak@amgen.com
Miller
P J
PJ
Jiao
S
S
Araujo
D M
DM
Hilt
D
D
Collins
F
F
D000818:Animals; D002460:Cell Line; D002490:Central Nervous System / Q000187:drug effects; D051100:Glial Cell Line-Derived Neurotrophic Factor; D006801:Humans; D009414:Nerve Growth Factors; D009416:Nerve Regeneration; D009419:Nerve Tissue Proteins / Q000494:pharmacology / Q000502:physiology* / Q000627:therapeutic use; D018696:Neuroprotective Agents / Q000494:pharmacology / Q000627:therapeutic use; D010300:Parkinson Disease / Q000188:drug therapy
C495039:GDNF protein, human; D051100:Glial Cell Line-Derived Neurotrophic Factor; D009414:Nerve Growth Factors; D009419:Nerve Tissue Proteins; D018696:Neuroprotective Agents